| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $504,542 ) |
| | 2024 | 2024 | UNIVERSITY OF SYDNEY | RESEARCH OFFICE MAIN QUADRANGLE A14 | THE UNIVERSITY OF SYDNEY | | | | AUS | R01CA285772 | Genomic bases for African geo-ethnic prostate cancer health disparity | 000 | 1 | NIH | 3/22/2024 | $500,626 |
| | 2024 | 2023 | UNIVERSITY OF SYDNEY | RESEARCH OFFICE MAIN QUADRANGLE A14 | THE UNIVERSITY OF SYDNEY | | | | AUS | R01DA054967 | The role of the lateral hypothalamus in the balance of learning and behavior towards relevant stimuli | 001 | 2 | NIH | 3/6/2024 | $3,916 |
|
| Issue Date FY: 2023 ( Subtotal = $1,220,875 ) |
| | 2023 | 2023 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI167641 | Combining immunogenic peptides and Nef blockade to enhance CD8 T-cell-mediated clearance of HIV-infected cells | 000 | 2 | NIH | 8/3/2023 | $160,878 |
| | 2023 | 2023 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R01AA030575 | Mapping the Neurobiological Risks and Consequences of Alcohol Use in Adolescence and Across the Lifespan | 000 | 1 | NIH | 9/15/2023 | $239,477 |
| | 2023 | 2023 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R01DA054967 | The role of the lateral hypothalamus in the balance of learning and behavior towards relevant stimuli | 002 | 2 | NIH | 7/3/2023 | $285,884 |
| | 2023 | 2023 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 001 | 24 | NIH | 9/14/2023 | $534,636 |
| | 2023 | 2022 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 000 | 23 | NIH | 9/12/2023 | $0 |
| | 2023 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI146442 | Cytomegalovirus as a risk factor for exacerbation of Mycobacterium tuberculosis infection | 000 | 3 | NIH | 4/17/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $839,114 ) |
| | 2022 | 2022 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI167641 | Combining immunogenic peptides and Nef blockade to enhance CD8 T-cell-mediated clearance of HIV-infected cells | 000 | 1 | NIH | 8/17/2022 | $136,122 |
| | 2022 | 2022 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 001 | 23 | NIH | 6/3/2022 | $450,895 |
| | 2022 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI146442 | Cytomegalovirus as a risk factor for exacerbation of Mycobacterium tuberculosis infection | 000 | 3 | NIH | 11/4/2021 | $95,707 |
| | 2022 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI146442 | Cytomegalovirus as a risk factor for exacerbation of Mycobacterium tuberculosis infection | 006 | 3 | NIH | 3/21/2022 | $116,597 |
| | 2022 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI146442 | Cytomegalovirus as a risk factor for exacerbation of Mycobacterium tuberculosis infection | 005 | 3 | NIH | 3/18/2022 | $156,390 |
| | 2022 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI146442 | Cytomegalovirus as a risk factor for exacerbation of Mycobacterium tuberculosis infection | 008 | 3 | NIH | 4/1/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 000 | 22 | NIH | 10/14/2021 | $0 |
| | 2022 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI146442 | Cytomegalovirus as a risk factor for exacerbation of Mycobacterium tuberculosis infection | 007 | 3 | NIH | 3/22/2022 | -$116,597 |
| | 2022 | 2020 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | U01FD006525 | Development of computational models to predict delivery of inhalation drug powders: from deagglomeration in devices to deposition in airways | 000 | 3 | FDA | 12/22/2021 | $0 |
| | 2022 | 2018 | UNIVERSITY OF SYDNEY | Level 3, Administration Building F23 | The University Of Sydney | NSW | | | AUS | ORIIR180038 | The seek & blastn tool as an experimental reagent fact-checker for biomedical research | 03 | 1 | DHHS/OS | 12/13/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $447,214 ) |
| | 2021 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 001 | 22 | NIH | 8/6/2021 | $0 |
| | 2021 | 2021 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 000 | 22 | NIH | 8/2/2021 | $452,839 |
| | 2021 | 2020 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 000 | 5 | NIH | 9/9/2021 | $0 |
| | 2021 | 2019 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | R21AI134204 | Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy | 000 | 2 | NIH | 12/29/2020 | $0 |
| | 2021 | 2017 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | | | AUS | F32AI120789 | The Role of Follicular Dendritic Cells in Maintenance of Persistent HIV | 000 | 2 | NIH | 12/31/2020 | -$5,625 |
|
| Issue Date FY: 2020 ( Subtotal = $683,683 ) |
| | 2020 | 2020 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 000 | 21 | NIH | 5/18/2020 | $452,839 |
| | 2020 | 2020 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 000 | 5 | NIH | 11/29/2019 | $210,844 |
| | 2020 | 2020 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | U01FD006525 | Development of computational models to predict delivery of inhalation drug powders: from deagglomeration in devices to deposition in airways | 002 | 3 | FDA | 7/21/2020 | $20,000 |
| | 2020 | 2019 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | U01FD006525 | Development of computational models to predict delivery of inhalation drug powders: from deagglomeration in devices to deposition in airways | 000 | 2 | FDA | 10/16/2019 | $21,000 |
| | 2020 | 2019 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | U01FD006525 | Development of computational models to predict delivery of inhalation drug powders: from deagglomeration in devices to deposition in airways | 001 | 2 | FDA | 10/30/2019 | -$21,000 |
| | 2020 | 2018 | UNIVERSITY OF SYDNEY | Level 3, Administration Building F23 | The University Of Sydney | NSW | 2006 | | AUS | ORIIR180038 | The seek & blastn tool as an experimental reagent fact-checker for biomedical research | 02 | 1 | DHHS/OS | 6/30/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,010,153 ) |
| | 2019 | 2019 | UNIVERSITY OF SYDNEY | L3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 000 | 4 | NIH | 11/7/2018 | $228,194 |
| | 2019 | 2019 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 000 | 20 | NIH | 6/25/2019 | $452,839 |
| | 2019 | 2019 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R21AI134204 | Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy | 000 | 2 | NIH | 5/29/2019 | $139,120 |
| | 2019 | 2019 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | U01FD006525 | Development of computational models to predict delivery of inhalation drug powders: from deagglomeration in devices to deposition in airways | 001 | 2 | FDA | 7/29/2019 | $190,000 |
| | 2019 | 2018 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | ORIIR180038 | The seek & blastn tool as an experimental reagent fact-checker for biomedical research | 01 | 1 | DHHS/OS | 7/17/2019 | $0 |
| | 2019 | 2018 | UNIVERSITY OF SYDNEY | L3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | U01FD006525 | Development of computational models to predict delivery of inhalation drug powders: from deagglomeration in devices to deposition in airways | 000 | 1 | FDA | 2/8/2019 | $0 |
| | 2019 | 2017 | UNIVERSITY OF SYDNEY | LEVEL 3, ADMINISTRATION BUILDING F23 | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R21AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 000 | 2 | NIH | 11/6/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,104,221 ) (Continued on the next page) |
| | 2018 | 2018 | UNIVERSITY OF SYDNEY | L3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | U01FD006525 | Development of computational models to predict delivery of inhalation drug powders: from deagglomeration in devices to deposition in airways | 001 | 1 | FDA | 8/29/2018 | -$190,000 |
| | 2018 | 2018 | UNIVERSITY OF SYDNEY | L3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 002 | 3 | NIH | 4/5/2018 | -$159,208 |
| | 2018 | 2018 | UNIVERSITY OF SYDNEY | L3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 002 | 3 | NIH | 4/5/2018 | $159,208 |
| | 2018 | 2018 | UNIVERSITY OF SYDNEY | L 3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 001 | 3 | NIH | 1/9/2018 | $159,208 |
| | 2018 | 2018 | UNIVERSITY OF SYDNEY | L 3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 001 | 3 | NIH | 1/9/2018 | -$159,208 |
| | 2018 | 2018 | UNIVERSITY OF SYDNEY | L 3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R33AI121627 | Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach | 000 | 3 | NIH | 12/23/2017 | $159,208 |
| | 2018 | 2018 | UNIVERSITY OF SYDNEY | L3 K07 MARGARET TELFER BUILDING | THE UNIVERSITY OF SYDNEY | NSW | 2006 | | AUS | R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 000 | 19 | NIH | 7/3/2018 | $452,839 |
|
